← FDA Drug Approvals (Drugs@FDA)

LIFYORLI (COPACKAGED)

NDA · New Drug Application · Sponsor: CORCEPT THERAP · Approved 2026-03-25

Drug application

FDA Application #

NDA220641

Application type

New Drug Application

Brand name

LIFYORLI (COPACKAGED)

Generic name

RELACORILANT

Active ingredients

RELACORILANT

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

CORCEPT THERAP

Manufacturer

Corcept Therapeutics Incorporated

First approval

2026-03-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown